The Recall Desk
ModerateFDA (Drugs)·D-0318-2025·Announced 2025-04-16

Prescription Voriconazole Antifungal Tablets Recalled Nationwide for Manufacturing Deviations

Glenmark Pharmaceuticals is voluntarily recalling Voriconazole tablets nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is a voluntary Class II recall due to manufacturing process deviations with no reported illnesses, injuries, or deaths. The recall addresses quality control compliance issues rather than a confirmed product hazard.

Plain-English summary

Glenmark Pharmaceuticals Inc. USA is voluntarily recalling Voriconazole tablets (200 mg, 30-count bottles) due to manufacturing process deviations identified as Current Good Manufacturing Practice (CGMP) violations. The FDA classified this as a Class II recall. Voriconazole is an antifungal medication.

Eight lots of the product with expiration dates ranging from March 2025 to September 2026 are affected by the recall. Distribution has been nationwide throughout the United States. No illnesses or injuries related to this product have been reported.

Consumers who have Voriconazole from one of the affected lots should contact their pharmacist or healthcare provider for further information and guidance regarding their use of the product.

The recalled product

Product
VORICONAZOLE (VORICONAZOLE)
Brand
VORICONAZOLE
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Category
Drug — Antifungal
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (9)

  • Lot # 17230853
  • exp. date Mar-25 17231271
  • exp. date May-25 17231300
  • exp. date May-25 17242050
  • exp. date Oct-26 17231046
  • exp. date Apr-25 17241156
  • exp. date Jun-26 17241388
  • exp. date Jul-26 17241800
  • exp. date Sep-26

UPCs (1)

  • 0368462573303

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 39 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 39 products in this recall →

Related recalls

Same brand · VORICONAZOLE

Same manufacturer · Glenmark Pharmaceuticals Inc., USA

See all →

Same hazard · cgmp deviation

See all →